Clinical Trials Sponsored by ISA+Pharmaceuticals

Total 22554 results

MedDay Pharmaceuticals SA

Completed

Effect of MD1003 in Amyotrophic Lateral Sclerosis (MD1003-ALS)

Motor Neuron Disease | Amyotrophic Lateral Sclerosis | ALS

France
Rhizen Pharmaceuticals SA

Completed

Safety and Efficacy Study of a Dual PI3K Delta/Gamma Inhibitor in Hematological Malignancies (PI3K)

Lymphoma, B-Cell | T-Cell Lymphoma

France, Italy
Rhizen Pharmaceuticals SA

Completed

Efficacy and Safety of Tenalisib (RP6530), a PI3K δ/γ and SIK3 Inhibitor, in Patients With Locally Advanced or Metastatic Breast Cancer

Metastatic Breast Cancer | Locally Advanced Breast Cancer

Georgia
Rhizen Pharmaceuticals SA

Withdrawn

Study to Evaluate the Safety, Pharmacokinetics and Clinical Activity of RP7214 in Combination With Azacitidine in Patients With Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia and Acute Myeloid Leukemia

Acute Myeloid Leukemia | Myelodysplastic Syndromes | Chronic Myelomonocytic Leukemia
Rhizen Pharmaceuticals SA

Withdrawn

Study to Evaluate the Efficacy and Safety of Tenalisib, Given With CHOP Therapy for Front Line Treatment in Patients With PTCL

Peripheral T Cell Lymphoma

United States
Rhizen Pharmaceuticals SA

Completed

Efficacy and Safety Study of Tenalisib (RP6530), a Novel PI3K δ/γ Dual Inhibitor in Patients With Relapsed/Refractory Indolent Non-Hodgkin's Lymphoma (iNHL)

Non Hodgkin Lymphoma

United States, Australia
MedDay Pharmaceuticals SA

Completed

SERENDEM : MD1003 in Patients Suffering From Demyelinating Neuropathies, an Open Label Pilot Study

Charcot-Marie-Tooth Disease | Peripheral Neuropathy | Chronic Inflammatory Demyelinating Polyneuropathy | Charcot-Marie-Tooth Disease Type 1A | Charcot-Marie-Tooth Disease, Type 1B | Anti-MAG Neuropathy

France
Rhizen Pharmaceuticals SA

Terminated

Safety, Tolerability and Pharmacokinetics of Oral Doses of RP3128 of Rhizen Pharmaceuticals

Asthma | Healthy Volunteers

Canada
MedDay Pharmaceuticals SA

Unknown

Effect of MD1003 in Chronic Visual Loss Related to Optic Neuritis in Multiple Sclerosis (MS-ON)

Multiple Sclerosis

United Kingdom, France
MedDay Pharmaceuticals SA

Unknown

Effect of MD1003 in Spinal Progressive Multiple Sclerosis (MS-SPI)

Multiple Sclerosis

France
Fovea Pharmaceuticals SA

Completed

Safety and Efficacy Study of Topical Administration of FOV2304 (High Dose or Low Dose) for the Treatment of Center-involving Clinically Significant Macular Edema Associated With Diabetic Retinopathy

Diabetic Macular Edema

United States, Australia, Belgium, Czech Republic, France, Germany, Israel, Italy, Poland, Spain
Fovea Pharmaceuticals SA

Completed

Evaluation of Efficacy of Coadministration of FOV1101-00 and Prednisolone Acetate in Patients With Mild Ongoing Ocular Allergic Inflammation

Allergic Conjunctivitis

United States
IBSA Institut Biochimique SA

Recruiting

Subcutaneous Progesterone in Frozen- Thawed Single Euploid Blastocyst Transfer. (PROGRESS)

Infertility

United States
IBSA Institut Biochimique SA

Withdrawn

TreatMent Of Knee osTeoarthritis wIth chONdroitin Sulfate - the OA MOTION Study (MOTION)

Knee Osteoarthritis
IBSA Institut Biochimique SA

Completed

A Study to Evaluate the Clinical Performance and Safety of an Intra-articular Hyaluronic Acid in Knee Osteoarthritis

Knee Osteoarthritis

Poland, Germany, Italy, Belgium, Hungary
IBSA Institut Biochimique SA

Terminated

Progesterone in Threatened Abortion

Threatened Abortion in First Trimester

Italy
IBSA Institut Biochimique SA

Completed

Condrosulf vs Celebrex vs Placebo in the Treatment of Knee OA

Knee Osteoarthritis

Belgium, Czech Republic, Italy, Poland, Switzerland
IBSA Institut Biochimique SA

Recruiting

A New Sildenafil Oral Film in Patients With Erectile Dysfunction

Erectile Dysfunction

United States
IBSA Institut Biochimique SA

Recruiting

Study of PK and Safety of the LicartTM Topical System in Pediatric and Adult Participants With Minor Soft Tissue Injury

Soft Tissue Injuries

United States
IBSA Institut Biochimique SA

Completed

Prolutex in Frozen Embryo Transfer Cycles at the Blastocyst Stage (PROGEX) (PROGEX)

Infertility

Spain
IBSA Institut Biochimique SA

Completed

Safety Study of Flector Patch in Children With Minor Soft Tissue Injuries

Athletic Injuries

United States
IBSA Institut Biochimique SA

Completed

Immunogenicity of Repeated Follicle Stimulating Hormone (FSH) Stimulation Cycles

Oocyte Donation

Spain
IBSA Institut Biochimique SA

Completed

Safety and Efficacy Study in in Vitro Fertilisation (IVF) Patients

Infertility

Switzerland, Denmark, France, Hungary, United Kingdom
IBSA Institut Biochimique SA

Completed

Subcutaneous Progesterone Versus Vaginal Progesterone Gel for Luteal Phase Support in Patients Undergoing In-Vitro Fertilization (IVF)

In Vitro Fertilization

Italy, United Kingdom, Germany, Hungary, Switzerland
IBSA Institut Biochimique SA

Completed

Evaluation of the Efficacy and Safety of Diclofenac HPBCD 25, 50 mg/ml in the Treatment of Post-surgical Pain Following Dental Surgery

Dental Pain

United Kingdom, Poland
IBSA Institut Biochimique SA

Completed

Evaluation of the Efficacy and Safety of Diclofenac HPBCD 75mg/ml in Treatment of Pain Following Dental Surgery

Dental Pain

United Kingdom
IBSA Institut Biochimique SA

Completed

Clinical Study of Clinical Efficacy and Tolerability of hMG-IBSA s.c.in Women Undergoing COH in an ART Programme (IVF).

Infertility

Italy
IBSA Institut Biochimique SA

Completed

Prospective, Randomized, Controlled, Clinical Study on Tolerability and Efficacy of hMG-IBSA

Infertility

Italy
Franciscus Gasthuis
Teva Pharmaceuticals USA

Recruiting

Expertise Asthma COPD Program With Digital Support (EXACT@home)

Asthma

Netherlands
Gan and Lee Pharmaceuticals, USA

Active, not recruiting

A Study of GZR18 Injection in Chinese Patients With Type 2 Diabetes Mellitus

Type 2 Diabetes

China
Gan and Lee Pharmaceuticals, USA

Completed

Single, Ascending Dose, First Time in Human Study for GZR18 in Healthy Subjects

Diabetes Mellitus, Type 2

United States
Gan and Lee Pharmaceuticals, USA

Completed

Gan & Lee Insulin Glargine Target Type (2) Evaluating Research (GLITTER 2)

Diabetes Mellitus, Type 2

United States
Gan and Lee Pharmaceuticals, USA

Withdrawn

Gan & Lee Evaluation of New Biosimilar for Type 1 Lispro (GENTL 1)

Diabetes Mellitus, Type 1

United States, Spain, Hungary, Poland, Germany, Czechia
Actavis Inc.
Teva Pharmaceuticals USA

Completed

Randomized, Placebo-Controlled, Multidose, Study Comparing Generic Budesonide/Formoterol Fumarate Dihydrate to Symbicort® in Asthmatic Participants

Asthma

United States
Gan and Lee Pharmaceuticals, USA

Completed

Gan & Lee Insulin Glargine Target Type (1) Evaluating Research (GLITTER1)

Diabetes Mellitus, Type 1

Spain, United States, Germany, Czechia, Hungary, Poland
Gan and Lee Pharmaceuticals, USA

Completed

A Study of GZR18 Injection in Chinese Obese/Overweight Patients

Obesity | Overweight

China
Gan and Lee Pharmaceuticals, USA

Enrolling by invitation

A Trial Comparing Efficacy and Safety of GZR101 and IDegAsp in Insulin Naïve or Insulin Treated Subjects With T2DM

Type 2 Diabetes

China
Actavis Inc.
Teva Pharmaceuticals USA

Completed

Therapeutic Equivalence of Two Formulations of Fluticasone Propionate and Salmeterol Inhalation Powder in Subjects With Asthma

Asthma

United States
Actavis Inc.
Teva Pharmaceuticals USA

Completed

A Clinical Endpoint Bioequivalence Study of "Oxymetazoline Hydrochloride Cream"

Rosacea

United States
Actavis Inc.
Teva Pharmaceuticals USA

Completed

Clinical Endpoint Study of Ivermectin 0.5% Lotion

Head Lice

United States
Emory University
Teva Pharmaceuticals USA

Terminated

Omacetaxine for Consolidation and Maintenance

Acute Myelogenous Leukemia (AML)

United States
Gan and Lee Pharmaceuticals, USA

Completed

PK/PD Study of Gan & Lee's Insulin Glargine Injection in Comparison to Lantus in Type 1 Diabetes

Diabetes Mellitus, Type 1

United States
Brown University
Teva Pharmaceuticals USA

Completed

The Effect of Rasagiline on Cognition in Parkinson's Disease

Parkinson's Disease

United States
Yuejia Pharmaceuticals (USA), Inc.
Zhejiang Yuejia Pharmaceuticals Co., Ltd.

Completed

Single-Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of YJ001 in Healthy Volunteers

Safety and Tolerability

United States
University Medical Center Groningen
ISA Pharmaceuticals B.V.; Dutch Cancer Society

Completed

p53 Synthetic Long Peptides Vaccine With Cyclophosphamide for Ovarian Cancer (ISA-P53-CTX)

Ovarian Cancer

Netherlands
Northside Hospital, Inc.
Teva Pharmaceuticals USA

Completed

High Dose Chemotherapy Using BeEAM for Autologous Transplant in Multiple Myeloma

Multiple Myeloma

United States
Achieve Life Sciences
Teva Pharmaceuticals USA

Terminated

A Study Evaluating the Pain Palliation Benefit of Adding Custirsen to Docetaxel Retreatment or Cabazitaxel as Second Line Therapy in Men With Metastatic Castrate Resistant Prostate Cancer (mCRPC)

Hormone Refractory Prostate Cancer | Castrate-Resistant Prostate Cancer

France, United States, Spain, United Kingdom, Canada
University at Buffalo
Teva Pharmaceuticals USA

Completed

Studying the Effects of Copaxone on Retinal Health Using Optical Tomography Over 24 Months (GAO)

Multiple Sclerosis

United States
Kennedy Medical Group
Teva Pharmaceuticals USA

Terminated

Efficacy and Safety of Cyclobenzaprine Hydrochloride Extended Release for the Treatment of Chronic Migraine

Chronic Migraine

United States
M.D. Anderson Cancer Center
Bristol-Myers Squibb; ISA Pharmaceuticals B.V.

Completed

Nivolumab and HPV-16 Vaccination in Patients With HPV-16 Positive Incurable Solid Tumors

Solid Tumors

United States

3

Subscribe